2m 2m 2m 2m 2m 2m 2m
PROTARA THERAPEU (TARA)
NASDAQ
$4.30+$0.12 (+2.75%)
Price as of Jul 14, 2026 6:43 AM EDT- $234.9MMarket Cap
- 32.28%1-Year Change
- BiotechnologyIndustry
PROTARA THERAPEU (TARA)
$4.30+$0.12 (+2.75%)
TARA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.18 | ||
Change | -$0.14 (-3.24%) | ||
Open | $4.27 | ||
High | $4.30 | ||
Low | $4.13 | ||
Previous Close | $4.32 | ||
Volume | 459,566 | ||
30-Day Average Volume | 804,462 | ||
1-Week Change | 2.45% | ||
1-Month Change | 7.18% | ||
1-Year Change | 32.28% | ||
3-Year Change | 48.23% | ||
5-Year Change | -52.66% | ||
Fundamentals | |||
Shares Outstanding | 56.2M | ||
Total Assets | $191.9M | ||
Market Cap | $234.9M | ||
Enterprise Value | $220.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$21.3M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.7M | ||
Net Working Capital | $131.1M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | -1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue